Fangfang Duan Selected Research

Fangfang Duan Research Topics

Disease

24	Neoplasms (Cancer) 05/2024 - 06/2012
6	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2020
4	Triple Negative Breast Neoplasms 05/2024 - 01/2021
4	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 06/2012
4	Inflammation (Inflammations) 08/2023 - 01/2015
3	Acne Vulgaris 03/2024 - 12/2022
3	Cicatrix (Scar) 03/2024 - 12/2022
3	Insulin Resistance 11/2023 - 12/2016
3	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2016
3	Stomach Neoplasms (Stomach Cancer) 01/2017 - 01/2016
3	Liver Cirrhosis (Hepatic Cirrhosis) 07/2015 - 01/2013
2	Sarcopenia 01/2023 - 01/2023
2	Brain Ischemia (Cerebral Ischemia) 05/2022 - 01/2020
2	Reperfusion Injury 05/2022 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2022
1	Infections 03/2024
1	Alcoholic Hepatitis 11/2023
1	Overweight 11/2023
1	Obesity 11/2023
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 10/2023
1	Bone Fractures (Bone Fracture) 08/2023
1	Brain Diseases (Brain Disorder) 08/2023
1	Edema (Dropsy) 08/2023
1	Sepsis (Septicemia) 08/2023
1	Cardiotoxicity 05/2023
1	Hematologic Neoplasms (Hematological Malignancy) 05/2023
1	Alcoholism (Alcohol Abuse) 01/2023
1	Liver Diseases (Liver Disease) 01/2023
1	Erythema 12/2022
1	Pain (Aches) 12/2022
1	Ossification of Posterior Longitudinal Ligament 11/2022
1	Postoperative Hemorrhage 11/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2022
1	Cerebral Infarction 05/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2022
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Lung Neoplasms (Lung Cancer) 11/2020

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 08/2023 - 01/2013
5	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2022
2	Capecitabine (Xeloda)FDA Link 05/2024 - 03/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 05/2023
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
2	CreatinineIBA 01/2023 - 01/2023
2	Indicators and Reagents (Reagents)IBA 01/2022 - 12/2016
2	IronIBA 01/2022 - 01/2021
2	Receptors for Activated C KinaseIBA 01/2018 - 01/2013
2	HexosaminesIBA 03/2017 - 12/2016
2	Glucose (Dextrose)FDA LinkGeneric 03/2017 - 12/2016
1	MetalsIBA 03/2024
1	Pentoxifylline (Trental)FDA LinkGeneric 11/2023
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2023
1	Lipoproteins (Lipoprotein)IBA 11/2023
1	Triglycerides (Triacylglycerol)IBA 11/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023
1	SteroidsIBA 10/2023
1	Polysaccharides (Glycans)IBA 10/2023
1	TitaniumIBA 08/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 08/2023
1	Immune Checkpoint ProteinsIBA 01/2023
1	AlbuminsIBA 01/2023
1	Baclofen FDA LinkGeneric 01/2023
1	NitrogenIBA 01/2023
1	Phosphorus (Red Phosphorus)IBA 01/2023
1	Prealbumin (Transthyretin)IBA 01/2023
1	Protons (Proton)IBA 01/2023
1	Urea (Carbamide)FDA LinkGeneric 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 10/2022
1	PlatinumIBA 10/2022
1	Etoposide (VP 16)FDA LinkGeneric 10/2022
1	Long Noncoding RNAIBA 10/2022
1	Carboplatin (JM8)FDA LinkGeneric 10/2022
1	anlotinibIBA 10/2022
1	Dexmedetomidine FDA Link 05/2022
1	triphenyltetrazoliumIBA 05/2022
1	salicylhydroxamic acid (SHAM)IBA 05/2022
1	human ERBB2 proteinIBA 03/2022
1	Vinorelbine (Navelbine)FDA LinkGeneric 03/2022
1	Lapatinib (GW572016)FDA Link 03/2022
1	Trastuzumab (Herceptin)FDA Link 03/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Nicotine FDA Link 01/2022
1	Threonine (L-Threonine)FDA Link 01/2022
1	Everolimus FDA Link 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	CopperIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020
1	LigandsIBA 11/2020
1	CytochalasinsIBA 11/2020

Therapy/Procedure

7	Therapeutics 03/2024 - 11/2020
3	Drug Therapy (Chemotherapy) 05/2024 - 01/2018
2	Lasers (Laser) 08/2023 - 12/2022
1	Aftercare (After-Treatment) 08/2023
1	Renal Dialysis (Hemodialysis) 01/2023
1	Operative Time 11/2022
1	Laminoplasty 11/2022
1	Sutures (Suture) 05/2022
1	Immunotherapy 01/2022
1	Adjuvant Chemotherapy 01/2022